We work around the world, expanding the geography and level of capitalization.
Our service is an additional and main income for doctors and specialists anywhere in the world.
Legal all over the world.
Growing up
Pricing
Frequently asked Questions
YDO HEALTH has no analogues in the market.
We are not telemedicine and do not fall under telemedicine law. This is an aggregator.
Our business model is non-profitable, as we do not employ doctors in staff.
We do not need to have a license and rent premises.
We can easily and quickly launch our service in any country.
The convenience for the client is that they can consult a doctor in their native language and set their own price from anywhere in the world. It is very convenient for doctors to work with us because we provide a large flow of clients, and they can consult at any convenient place and time.
For many doctors, this is their primary source of income.
There is nothing like this at the moment. In addition, we work worldwide. See presentation.
Because we do not make diagnoses, do not store client data, do not keep patient records, and work on the principle of a second opinion. We have fully legally provided for all these nuances and outlined them in our offer.
The client places a consultation task at his price or chooses a doctor for the price set by them. The platform receives 30% of the consultation cost. The remaining 70% goes to the doctor.
He can withdraw what he has earned in any convenient way.
The platform earns from paid placements of doctors and clinics (paid rating). Paid advertising placements.
Paid subscription.
Very soon, we are introducing new functionality that will allow conducting remote customer surveys (concierge service). This is very convenient for doctors as it saves them time on visiting patients.
Currently, we are operating in Russia, by the end of 2024, we will enter the markets of the UAE and Turkey, and then according to the roadmap (see the Presentation). These are the main directions that we will engage in the coming year.
The investor earns proportionally to his share.
The capitalization of the share increases with the growth of our product.
Currently, we are already operating with net profit in Russia. We plan to expand to MENA countries and launch within 4-6 months.
We offer the investor a 25% stake in the company. The cost of the company's share is $300,000 (at the time of this offer). The value of the share will increase further.
The investor earns with us, proportionally to his share. An approximate (pessimistic forecast) - with just a 10% market coverage = $250,000 per month.
The investor has access to all analytics and sales in his personal account.
The earlier the investor gets into the project, the more he earns.
Our goal is a public IPO.
We are not only aiming to obtain investments. It is very important for us that the investor becomes an active member of the team.
We need to obtain Smart money.
The ideal portrait of our partner:
A businessman.
Preferably from the medical field or with understanding of it.
Perhaps our partner will be a corporation that is considering such a project for its infrastructure and can increase sales within the system.
It could also be a clinic that lacks such functionality and needs such a product for itself and its specialists.
Our partner could also be a senior medical professional.
The partner could also be an existing businessman, developing his direction in healthcare.
In Russia, we are already working closely with several clinic networks, we have over 700 doctors and more than 3000 regular users. Our revenue is about 300,000 rubles per month, and this figure increases by approximately 15% monthly.